181 related articles for article (PubMed ID: 19008051)
1. Assessment of microvessel density and carbonic anhydrase-9 (CA-9) expression in rectal cancer.
Rasheed S; Harris AL; Tekkis PP; Turley H; Silver A; McDonald PJ; Talbot IC; Glynne-Jones R; Northover JM; Guenther T
Pathol Res Pract; 2009; 205(1):1-9. PubMed ID: 19008051
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma.
Kon-no H; Ishii G; Nagai K; Yoshida J; Nishimura M; Nara M; Fujii T; Murata Y; Miyamoto H; Ochiai A
Lung Cancer; 2006 Dec; 54(3):409-18. PubMed ID: 17030461
[TBL] [Abstract][Full Text] [Related]
3. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
[TBL] [Abstract][Full Text] [Related]
4. Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients.
Pérez-Sayáns M; Suárez-Peñaranda JM; Pilar GD; Supuran CT; Pastorekova S; Barros-Angueira F; Gándara-Rey JM; García-García A
J Oral Pathol Med; 2012 Oct; 41(9):667-74. PubMed ID: 22486898
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-Associated Marker CA IX Does Not Predict the Response of Locally Advanced Rectal Cancers to Neoadjuvant Chemoradiotherapy.
Mayer A; Vaupel P; Oberholzer K; Ebert M; Dimitrow M; Kreft A; Mueller-Klieser W; Schmidberger H
Adv Exp Med Biol; 2016; 876():195-200. PubMed ID: 26782212
[TBL] [Abstract][Full Text] [Related]
6. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis.
Martinović Ž; Kovač D; Martinović C
World J Surg Oncol; 2016 Apr; 14():122. PubMed ID: 27102733
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
[TBL] [Abstract][Full Text] [Related]
8. Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer.
Korkeila E; Talvinen K; Jaakkola PM; Minn H; Syrjänen K; Sundström J; Pyrhönen S
Br J Cancer; 2009 Mar; 100(6):874-80. PubMed ID: 19240720
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis.
Rasheed S; Harris AL; Tekkis PP; Turley H; Silver A; McDonald PJ; Talbot IC; Glynne-Jones R; Northover JM; Guenther T
Br J Cancer; 2009 May; 100(10):1666-73. PubMed ID: 19436307
[TBL] [Abstract][Full Text] [Related]
10. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma.
Yu WD; Peng YF; Pan HD; Wang L; Li K; Gu J
World J Gastroenterol; 2014 Nov; 20(43):16258-67. PubMed ID: 25473181
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX in early-stage non-small cell lung cancer.
Kim SJ; Rabbani ZN; Vollmer RT; Schreiber EG; Oosterwijk E; Dewhirst MW; Vujaskovic Z; Kelley MJ
Clin Cancer Res; 2004 Dec; 10(23):7925-33. PubMed ID: 15585626
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas.
Viikilä P; Kivelä AJ; Mustonen H; Koskensalo S; Waheed A; Sly WS; Pastorek J; Pastorekova S; Parkkila S; Haglund C
World J Gastroenterol; 2016 Sep; 22(36):8168-77. PubMed ID: 27688658
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
[TBL] [Abstract][Full Text] [Related]
16. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.
Li G; Feng G; Gentil-Perret A; Genin C; Tostain J
J Urol; 2008 Aug; 180(2):510-3; discussion 513-4. PubMed ID: 18550116
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials.
Kyndi M; Sørensen FB; Knudsen H; Alsner J; Overgaard M; Nielsen HM; Overgaard J;
Breast Cancer Res; 2008; 10(2):R24. PubMed ID: 18355402
[TBL] [Abstract][Full Text] [Related]
18. Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers.
Sakata K; Someya M; Nagakura H; Nakata K; Oouchi A; Takagi M; Hareyama M
Jpn J Clin Oncol; 2008 Jun; 38(6):402-7. PubMed ID: 18573850
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.
Beasley NJ; Wykoff CC; Watson PH; Leek R; Turley H; Gatter K; Pastorek J; Cox GJ; Ratcliffe P; Harris AL
Cancer Res; 2001 Jul; 61(13):5262-7. PubMed ID: 11431368
[TBL] [Abstract][Full Text] [Related]
20. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
